COVID-19 Impact on Global Biosimilars/Follow-on-Biologics, Market Insights and Forecast to 2026
Biosimilars/Follow-on-Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/Follow-on-Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilars/Follow-on-Biologics market is segmented into
The Biosimilars/Follow-on-Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars/Follow-on-Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars/Follow-on-Biologics business, the date to enter into the Biosimilars/Follow-on-Biologics market, Biosimilars/Follow-on-Biologics product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Biosimilars/Follow-on-Biologics market is segmented into
- Human growth hormone
- Erythropoietin
- Monoclonal antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
- Peptide
- Others
- Blood disorders
- Oncology diseases
- Chronic and autoimmune diseases
- Growth hormone deficiencies
- Others
The Biosimilars/Follow-on-Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars/Follow-on-Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars/Follow-on-Biologics business, the date to enter into the Biosimilars/Follow-on-Biologics market, Biosimilars/Follow-on-Biologics product introduction, recent developments, etc.
The major vendors covered:
- Novartis
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion
- Biocon
- Hospira
- Merck Group
- Biogen idec, Inc.
- Genentech (Roche Group)
1 STUDY COVERAGE
1.1 Biosimilars/Follow-on-Biologics Product Introduction
1.2 Market Segments
1.3 Key Biosimilars/Follow-on-Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Peptide
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Application
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars/Follow-on-Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilars/Follow-on-Biologics Industry
1.6.1.1 Biosimilars/Follow-on-Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilars/Follow-on-Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilars/Follow-on-Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biosimilars/Follow-on-Biologics Market Size Estimates and Forecasts
2.1.1 Global Biosimilars/Follow-on-Biologics Revenue 2015-2026
2.1.2 Global Biosimilars/Follow-on-Biologics Sales 2015-2026
2.2 Biosimilars/Follow-on-Biologics Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers
3.1.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers (2015-2020)
3.1.2 Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilars/Follow-on-Biologics Revenue by Manufacturers
3.2.1 Biosimilars/Follow-on-Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilars/Follow-on-Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilars/Follow-on-Biologics Revenue in 2019
3.2.5 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilars/Follow-on-Biologics Price by Manufacturers
3.4 Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars/Follow-on-Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars/Follow-on-Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.1.1 Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020)
4.1.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilars/Follow-on-Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.1.1 Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020)
5.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Application (2015-2020)
5.1.3 Biosimilars/Follow-on-Biologics Price by Application (2015-2020)
5.2 Biosimilars/Follow-on-Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilars/Follow-on-Biologics Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biosimilars/Follow-on-Biologics by Country
6.1.1 North America Biosimilars/Follow-on-Biologics Sales by Country
6.1.2 North America Biosimilars/Follow-on-Biologics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
6.3 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biosimilars/Follow-on-Biologics by Country
7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country
7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
7.3 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biosimilars/Follow-on-Biologics by Region
8.1.1 Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region
8.1.2 Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
8.3 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biosimilars/Follow-on-Biologics by Country
9.1.1 Latin America Biosimilars/Follow-on-Biologics Sales by Country
9.1.2 Latin America Biosimilars/Follow-on-Biologics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
9.3 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biosimilars/Follow-on-Biologics by Country
10.1.1 Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country
10.1.2 Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
11.1.5 Novartis Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Corporation Information
11.2.2 Synthon Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Products Offered
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Corporation Information
11.3.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.3.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Products Offered
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Corporation Information
11.4.2 LG Life Sciences Description, Business Overview and Total Revenue
11.4.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Products Offered
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion
11.5.1 Celltrion Corporation Information
11.5.2 Celltrion Description, Business Overview and Total Revenue
11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celltrion Biosimilars/Follow-on-Biologics Products Offered
11.5.5 Celltrion Recent Development
11.6 Biocon
11.6.1 Biocon Corporation Information
11.6.2 Biocon Description, Business Overview and Total Revenue
11.6.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biocon Biosimilars/Follow-on-Biologics Products Offered
11.6.5 Biocon Recent Development
11.7 Hospira
11.7.1 Hospira Corporation Information
11.7.2 Hospira Description, Business Overview and Total Revenue
11.7.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hospira Biosimilars/Follow-on-Biologics Products Offered
11.7.5 Hospira Recent Development
11.8 Merck Group
11.8.1 Merck Group Corporation Information
11.8.2 Merck Group Description, Business Overview and Total Revenue
11.8.3 Merck Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Group Biosimilars/Follow-on-Biologics Products Offered
11.8.5 Merck Group Recent Development
11.9 Biogen idec, Inc.
11.9.1 Biogen idec, Inc. Corporation Information
11.9.2 Biogen idec, Inc. Description, Business Overview and Total Revenue
11.9.3 Biogen idec, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Products Offered
11.9.5 Biogen idec, Inc. Recent Development
11.10 Genentech (Roche Group)
11.10.1 Genentech (Roche Group) Corporation Information
11.10.2 Genentech (Roche Group) Description, Business Overview and Total Revenue
11.10.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Products Offered
11.10.5 Genentech (Roche Group) Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Region
12.1.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.2.2 North America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilars/Follow-on-Biologics Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biosimilars/Follow-on-Biologics Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biosimilars/Follow-on-Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Biosimilars/Follow-on-Biologics Product Introduction
1.2 Market Segments
1.3 Key Biosimilars/Follow-on-Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Peptide
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Application
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars/Follow-on-Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilars/Follow-on-Biologics Industry
1.6.1.1 Biosimilars/Follow-on-Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilars/Follow-on-Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilars/Follow-on-Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biosimilars/Follow-on-Biologics Market Size Estimates and Forecasts
2.1.1 Global Biosimilars/Follow-on-Biologics Revenue 2015-2026
2.1.2 Global Biosimilars/Follow-on-Biologics Sales 2015-2026
2.2 Biosimilars/Follow-on-Biologics Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers
3.1.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers (2015-2020)
3.1.2 Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilars/Follow-on-Biologics Revenue by Manufacturers
3.2.1 Biosimilars/Follow-on-Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilars/Follow-on-Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilars/Follow-on-Biologics Revenue in 2019
3.2.5 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilars/Follow-on-Biologics Price by Manufacturers
3.4 Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars/Follow-on-Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars/Follow-on-Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.1.1 Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020)
4.1.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilars/Follow-on-Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.1.1 Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020)
5.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Application (2015-2020)
5.1.3 Biosimilars/Follow-on-Biologics Price by Application (2015-2020)
5.2 Biosimilars/Follow-on-Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilars/Follow-on-Biologics Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biosimilars/Follow-on-Biologics by Country
6.1.1 North America Biosimilars/Follow-on-Biologics Sales by Country
6.1.2 North America Biosimilars/Follow-on-Biologics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
6.3 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biosimilars/Follow-on-Biologics by Country
7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country
7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
7.3 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biosimilars/Follow-on-Biologics by Region
8.1.1 Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region
8.1.2 Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
8.3 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biosimilars/Follow-on-Biologics by Country
9.1.1 Latin America Biosimilars/Follow-on-Biologics Sales by Country
9.1.2 Latin America Biosimilars/Follow-on-Biologics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
9.3 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biosimilars/Follow-on-Biologics by Country
10.1.1 Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country
10.1.2 Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
11.1.5 Novartis Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Corporation Information
11.2.2 Synthon Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Products Offered
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Corporation Information
11.3.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.3.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Products Offered
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Corporation Information
11.4.2 LG Life Sciences Description, Business Overview and Total Revenue
11.4.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Products Offered
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion
11.5.1 Celltrion Corporation Information
11.5.2 Celltrion Description, Business Overview and Total Revenue
11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celltrion Biosimilars/Follow-on-Biologics Products Offered
11.5.5 Celltrion Recent Development
11.6 Biocon
11.6.1 Biocon Corporation Information
11.6.2 Biocon Description, Business Overview and Total Revenue
11.6.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biocon Biosimilars/Follow-on-Biologics Products Offered
11.6.5 Biocon Recent Development
11.7 Hospira
11.7.1 Hospira Corporation Information
11.7.2 Hospira Description, Business Overview and Total Revenue
11.7.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hospira Biosimilars/Follow-on-Biologics Products Offered
11.7.5 Hospira Recent Development
11.8 Merck Group
11.8.1 Merck Group Corporation Information
11.8.2 Merck Group Description, Business Overview and Total Revenue
11.8.3 Merck Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Group Biosimilars/Follow-on-Biologics Products Offered
11.8.5 Merck Group Recent Development
11.9 Biogen idec, Inc.
11.9.1 Biogen idec, Inc. Corporation Information
11.9.2 Biogen idec, Inc. Description, Business Overview and Total Revenue
11.9.3 Biogen idec, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Products Offered
11.9.5 Biogen idec, Inc. Recent Development
11.10 Genentech (Roche Group)
11.10.1 Genentech (Roche Group) Corporation Information
11.10.2 Genentech (Roche Group) Description, Business Overview and Total Revenue
11.10.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Products Offered
11.10.5 Genentech (Roche Group) Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Region
12.1.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.2.2 North America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilars/Follow-on-Biologics Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biosimilars/Follow-on-Biologics Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biosimilars/Follow-on-Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Biosimilars/Follow-on-Biologics Market Segments
Table 2. Ranking of Global Top Biosimilars/Follow-on-Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Human growth hormone
Table 5. Major Manufacturers of Erythropoietin
Table 6. Major Manufacturers of Monoclonal antibodies
Table 7. Major Manufacturers of Insulin
Table 8. Major Manufacturers of Interferon
Table 9. Major Manufacturers of Granulocyte-Colony Stimulating Factor
Table 10. Major Manufacturers of Peptide
Table 11. Major Manufacturers of Others
Table 12. COVID-19 Impact Global Market: (Four Biosimilars/Follow-on-Biologics Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Biosimilars/Follow-on-Biologics Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Biosimilars/Follow-on-Biologics Players to Combat Covid-19 Impact
Table 17. Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 18. Global Biosimilars/Follow-on-Biologics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 19. Global Biosimilars/Follow-on-Biologics Sales by Regions 2015-2020 (K Pcs)
Table 20. Global Biosimilars/Follow-on-Biologics Sales Market Share by Regions (2015-2020)
Table 21. Global Biosimilars/Follow-on-Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 22. Global Biosimilars/Follow-on-Biologics Sales by Manufacturers (2015-2020) (K Pcs)
Table 23. Global Biosimilars/Follow-on-Biologics Sales Share by Manufacturers (2015-2020)
Table 24. Global Biosimilars/Follow-on-Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 25. Global Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/Follow-on-Biologics as of 2019)
Table 26. Biosimilars/Follow-on-Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 27. Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2015-2020)
Table 28. Key Manufacturers Biosimilars/Follow-on-Biologics Price (2015-2020) (USD/Pcs)
Table 29. Biosimilars/Follow-on-Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Biosimilars/Follow-on-Biologics Product Type
Table 31. Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 34. Global Biosimilars/Follow-on-Biologics Sales Share by Type (2015-2020)
Table 35. Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020) (US$ Million)
Table 36. Global Biosimilars/Follow-on-Biologics Revenue Share by Type (2015-2020)
Table 37. Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 38. Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 39. Global Biosimilars/Follow-on-Biologics Sales Share by Application (2015-2020)
Table 40. North America Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 41. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 42. North America Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 43. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 44. North America Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 45. North America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 46. North America Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 47. North America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 48. Europe Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 49. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 50. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 51. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 52. Europe Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 53. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 54. Europe Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 55. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 56. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region (2015-2020) (K Pcs)
Table 57. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region (2015-2020)
Table 58. Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2015-2020) (US$ Million)
Table 59. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2015-2020)
Table 60. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 61. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 62. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 63. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 64. Latin America Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 65. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 66. Latin Americaa Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 67. Latin America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 68. Latin America Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 69. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 70. Latin America Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 71. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 72. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 73. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 77. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 78. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 79. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Major Businesses
Table 82. Novartis Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Novartis Product
Table 84. Novartis Recent Development
Table 85. Synthon Pharmaceuticals Corporation Information
Table 86. Synthon Pharmaceuticals Description and Major Businesses
Table 87. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Synthon Pharmaceuticals Product
Table 89. Synthon Pharmaceuticals Recent Development
Table 90. Teva Pharmaceutical Industries Corporation Information
Table 91. Teva Pharmaceutical Industries Description and Major Businesses
Table 92. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Teva Pharmaceutical Industries Product
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. LG Life Sciences Corporation Information
Table 96. LG Life Sciences Description and Major Businesses
Table 97. LG Life Sciences Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. LG Life Sciences Product
Table 99. LG Life Sciences Recent Development
Table 100. Celltrion Corporation Information
Table 101. Celltrion Description and Major Businesses
Table 102. Celltrion Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Celltrion Product
Table 104. Celltrion Recent Development
Table 105. Biocon Corporation Information
Table 106. Biocon Description and Major Businesses
Table 107. Biocon Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Biocon Product
Table 109. Biocon Recent Development
Table 110. Hospira Corporation Information
Table 111. Hospira Description and Major Businesses
Table 112. Hospira Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Hospira Product
Table 114. Hospira Recent Development
Table 115. Merck Group Corporation Information
Table 116. Merck Group Description and Major Businesses
Table 117. Merck Group Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Merck Group Product
Table 119. Merck Group Recent Development
Table 120. Biogen idec, Inc. Corporation Information
Table 121. Biogen idec, Inc. Description and Major Businesses
Table 122. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Biogen idec, Inc. Product
Table 124. Biogen idec, Inc. Recent Development
Table 125. Genentech (Roche Group) Corporation Information
Table 126. Genentech (Roche Group) Description and Major Businesses
Table 127. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Genentech (Roche Group) Product
Table 129. Genentech (Roche Group) Recent Development
Table 130. Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 131. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. North America: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Europe: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Biosimilars/Follow-on-Biologics Sales Forecast by Region (2021-2026) (K Pcs)
Table 139. Asia Pacific: Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Latin America: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Middle East and Africa: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Biosimilars/Follow-on-Biologics Players
Table 148. Biosimilars/Follow-on-Biologics Customers List
Table 149. Biosimilars/Follow-on-Biologics Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 1. Biosimilars/Follow-on-Biologics Market Segments
Table 2. Ranking of Global Top Biosimilars/Follow-on-Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Human growth hormone
Table 5. Major Manufacturers of Erythropoietin
Table 6. Major Manufacturers of Monoclonal antibodies
Table 7. Major Manufacturers of Insulin
Table 8. Major Manufacturers of Interferon
Table 9. Major Manufacturers of Granulocyte-Colony Stimulating Factor
Table 10. Major Manufacturers of Peptide
Table 11. Major Manufacturers of Others
Table 12. COVID-19 Impact Global Market: (Four Biosimilars/Follow-on-Biologics Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Biosimilars/Follow-on-Biologics Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Biosimilars/Follow-on-Biologics Players to Combat Covid-19 Impact
Table 17. Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 18. Global Biosimilars/Follow-on-Biologics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 19. Global Biosimilars/Follow-on-Biologics Sales by Regions 2015-2020 (K Pcs)
Table 20. Global Biosimilars/Follow-on-Biologics Sales Market Share by Regions (2015-2020)
Table 21. Global Biosimilars/Follow-on-Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 22. Global Biosimilars/Follow-on-Biologics Sales by Manufacturers (2015-2020) (K Pcs)
Table 23. Global Biosimilars/Follow-on-Biologics Sales Share by Manufacturers (2015-2020)
Table 24. Global Biosimilars/Follow-on-Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 25. Global Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/Follow-on-Biologics as of 2019)
Table 26. Biosimilars/Follow-on-Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 27. Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2015-2020)
Table 28. Key Manufacturers Biosimilars/Follow-on-Biologics Price (2015-2020) (USD/Pcs)
Table 29. Biosimilars/Follow-on-Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Biosimilars/Follow-on-Biologics Product Type
Table 31. Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 34. Global Biosimilars/Follow-on-Biologics Sales Share by Type (2015-2020)
Table 35. Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020) (US$ Million)
Table 36. Global Biosimilars/Follow-on-Biologics Revenue Share by Type (2015-2020)
Table 37. Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 38. Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 39. Global Biosimilars/Follow-on-Biologics Sales Share by Application (2015-2020)
Table 40. North America Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 41. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 42. North America Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 43. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 44. North America Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 45. North America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 46. North America Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 47. North America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 48. Europe Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 49. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 50. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 51. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 52. Europe Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 53. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 54. Europe Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 55. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 56. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region (2015-2020) (K Pcs)
Table 57. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region (2015-2020)
Table 58. Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2015-2020) (US$ Million)
Table 59. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2015-2020)
Table 60. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 61. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 62. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 63. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 64. Latin America Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 65. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 66. Latin Americaa Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 67. Latin America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 68. Latin America Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 69. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 70. Latin America Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 71. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 72. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country (2015-2020) (K Pcs)
Table 73. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 77. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Table 78. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 79. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Major Businesses
Table 82. Novartis Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Novartis Product
Table 84. Novartis Recent Development
Table 85. Synthon Pharmaceuticals Corporation Information
Table 86. Synthon Pharmaceuticals Description and Major Businesses
Table 87. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Synthon Pharmaceuticals Product
Table 89. Synthon Pharmaceuticals Recent Development
Table 90. Teva Pharmaceutical Industries Corporation Information
Table 91. Teva Pharmaceutical Industries Description and Major Businesses
Table 92. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Teva Pharmaceutical Industries Product
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. LG Life Sciences Corporation Information
Table 96. LG Life Sciences Description and Major Businesses
Table 97. LG Life Sciences Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. LG Life Sciences Product
Table 99. LG Life Sciences Recent Development
Table 100. Celltrion Corporation Information
Table 101. Celltrion Description and Major Businesses
Table 102. Celltrion Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Celltrion Product
Table 104. Celltrion Recent Development
Table 105. Biocon Corporation Information
Table 106. Biocon Description and Major Businesses
Table 107. Biocon Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Biocon Product
Table 109. Biocon Recent Development
Table 110. Hospira Corporation Information
Table 111. Hospira Description and Major Businesses
Table 112. Hospira Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Hospira Product
Table 114. Hospira Recent Development
Table 115. Merck Group Corporation Information
Table 116. Merck Group Description and Major Businesses
Table 117. Merck Group Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Merck Group Product
Table 119. Merck Group Recent Development
Table 120. Biogen idec, Inc. Corporation Information
Table 121. Biogen idec, Inc. Description and Major Businesses
Table 122. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Biogen idec, Inc. Product
Table 124. Biogen idec, Inc. Recent Development
Table 125. Genentech (Roche Group) Corporation Information
Table 126. Genentech (Roche Group) Description and Major Businesses
Table 127. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Genentech (Roche Group) Product
Table 129. Genentech (Roche Group) Recent Development
Table 130. Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 131. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. North America: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Europe: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Biosimilars/Follow-on-Biologics Sales Forecast by Region (2021-2026) (K Pcs)
Table 139. Asia Pacific: Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Latin America: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Biosimilars/Follow-on-Biologics Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Middle East and Africa: Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Biosimilars/Follow-on-Biologics Players
Table 148. Biosimilars/Follow-on-Biologics Customers List
Table 149. Biosimilars/Follow-on-Biologics Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Biosimilars/Follow-on-Biologics Product Picture
Figure 2. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Human growth hormone Product Picture
Figure 4. Erythropoietin Product Picture
Figure 5. Monoclonal antibodies Product Picture
Figure 6. Insulin Product Picture
Figure 7. Interferon Product Picture
Figure 8. Granulocyte-Colony Stimulating Factor Product Picture
Figure 9. Peptide Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application in 2020 & 2026
Figure 12. Blood disorders
Figure 13. Oncology diseases
Figure 14. Chronic and autoimmune diseases
Figure 15. Growth hormone deficiencies
Figure 16. Others
Figure 17. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 18. Global Biosimilars/Follow-on-Biologics Market Size 2015-2026 (US$ Million)
Figure 19. Global Biosimilars/Follow-on-Biologics Sales 2015-2026 (K Pcs)
Figure 20. Global Biosimilars/Follow-on-Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 21. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2015-2020)
Figure 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2019
Figure 23. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2015-2020)
Figure 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region in 2019
Figure 25. Global Biosimilars/Follow-on-Biologics Sales Share by Manufacturer in 2019
Figure 26. The Top 10 and 5 Players Market Share by Biosimilars/Follow-on-Biologics Revenue in 2019
Figure 27. Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2019
Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2015-2020)
Figure 31. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type in 2019
Figure 32. Global Biosimilars/Follow-on-Biologics Market Share by Price Range (2015-2020)
Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Figure 34. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application in 2019
Figure 35. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2015-2020)
Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2019
Figure 37. North America Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 38. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 40. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 41. U.S. Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. U.S. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Canada Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. North America Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 46. North America Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 47. Europe Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 48. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 50. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 51. Germany Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Germany Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. France Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. U.K. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Europe Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 62. Europe Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 63. Asia Pacific Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2019
Figure 66. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region in 2019
Figure 67. China Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Asia Pacific Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 90. Asia Pacific Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 91. Latin America Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 92. Latin America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 93. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 94. Latin America Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 95. Mexico Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Mexico Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Brazil Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Brazil Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Argentina Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Argentina Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Latin America Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 102. Latin America Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 103. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 104. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 105. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 106. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 107. Turkey Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Turkey Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Saudi Arabia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. Saudi Arabia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. U.A.E Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 112. U.A.E Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. Middle East and Africa Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 114. Middle East and Africa Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Synthon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Merck Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Biogen idec, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Genentech (Roche Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Latin America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
Figure 1. Biosimilars/Follow-on-Biologics Product Picture
Figure 2. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Human growth hormone Product Picture
Figure 4. Erythropoietin Product Picture
Figure 5. Monoclonal antibodies Product Picture
Figure 6. Insulin Product Picture
Figure 7. Interferon Product Picture
Figure 8. Granulocyte-Colony Stimulating Factor Product Picture
Figure 9. Peptide Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application in 2020 & 2026
Figure 12. Blood disorders
Figure 13. Oncology diseases
Figure 14. Chronic and autoimmune diseases
Figure 15. Growth hormone deficiencies
Figure 16. Others
Figure 17. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 18. Global Biosimilars/Follow-on-Biologics Market Size 2015-2026 (US$ Million)
Figure 19. Global Biosimilars/Follow-on-Biologics Sales 2015-2026 (K Pcs)
Figure 20. Global Biosimilars/Follow-on-Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 21. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2015-2020)
Figure 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2019
Figure 23. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2015-2020)
Figure 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region in 2019
Figure 25. Global Biosimilars/Follow-on-Biologics Sales Share by Manufacturer in 2019
Figure 26. The Top 10 and 5 Players Market Share by Biosimilars/Follow-on-Biologics Revenue in 2019
Figure 27. Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2015-2020)
Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2019
Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2015-2020)
Figure 31. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type in 2019
Figure 32. Global Biosimilars/Follow-on-Biologics Market Share by Price Range (2015-2020)
Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
Figure 34. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application in 2019
Figure 35. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2015-2020)
Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2019
Figure 37. North America Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 38. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 40. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 41. U.S. Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. U.S. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Canada Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. North America Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 46. North America Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 47. Europe Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 48. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 50. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 51. Germany Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Germany Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. France Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. U.K. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Europe Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 62. Europe Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 63. Asia Pacific Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2019
Figure 66. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region in 2019
Figure 67. China Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Asia Pacific Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 90. Asia Pacific Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 91. Latin America Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 92. Latin America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 93. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 94. Latin America Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 95. Mexico Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Mexico Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Brazil Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Brazil Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Argentina Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Argentina Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Latin America Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 102. Latin America Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 103. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Growth Rate 2015-2020 (K Pcs)
Figure 104. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 105. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2019
Figure 106. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2019
Figure 107. Turkey Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Turkey Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Saudi Arabia Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. Saudi Arabia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. U.A.E Biosimilars/Follow-on-Biologics Sales Growth Rate (2015-2020) (K Pcs)
Figure 112. U.A.E Biosimilars/Follow-on-Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. Middle East and Africa Biosimilars/Follow-on-Biologics Market Share by Type in 2019
Figure 114. Middle East and Africa Biosimilars/Follow-on-Biologics Market Share by Application in 2019
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Synthon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Merck Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Biogen idec, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Genentech (Roche Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Latin America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
